Flashpoint Therapeutics Scientific Founder, Chad Mirkin, Receives 2024 Kavli Prize for Groundbreaking Work on Spherical Nucleic Acids
Flashpoint announces signing of MoU with Ministry of Investment of Saudi Arabia to support discussions around our IPO and with King Abdullah International Medical Research Center (كيمارك KAIMRC) for hosting our clinical trials